-
Je něco špatně v tomto záznamu ?
Effect of co-processed excipient type on properties of orodispersible tablets containing captopril, tramadol, and domperidone
T. Tranová, J. Loskot, O. Navrátil, W. Brniak, J. Mužíková
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- aplikace orální MeSH
- domperidon MeSH
- kaptopril MeSH
- mannitol chemie MeSH
- pomocné látky * chemie MeSH
- příprava léků metody MeSH
- rozpustnost MeSH
- tablety chemie MeSH
- tramadol * MeSH
- Publikační typ
- časopisecké články MeSH
An important feature of orodispersible tablets (ODTs) is the convenient administration of the drugs, in some cases, faster onset of action, stability maintenance, and dose precision. This work focused on the preparation of ODTs containing mannitol-based co-processed excipients Prosolv® ODT G2, Ludiflash® and Parteck® ODT in combination with tramadol, captopril, and domperidone by direct compression. Prosolv® ODT G2 showed high energy of plastic deformation due to the content of microcrystalline cellulose. Parteck® ODT provided compact tablets due to the content of granulated mannitol. All drugs decreased tensile strength, increased friability, prolonged disintegration time, and decreased the porosity of tablets. Tablets containing Prosolv® ODT G2 with captopril, domperidone, and tramadol; and Parteck® ODT with domperidone met the requirements for ODTs production, i.e., friability ≤ 1% and disintegration time ≤ 180 s, fast wetting time, high water absorption ratio, and adequate tensile strength. The disintegration time was tested using both the pharmacopeial method and the BJKSN-13 apparatus. The results indicate the significant difference between these methods, with the disintegration time being longer when tested with the BJKSN-13 instrument.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23010489
- 003
- CZ-PrNML
- 005
- 20230801132447.0
- 007
- ta
- 008
- 230718s2023 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijpharm.2023.122838 $2 doi
- 035 __
- $a (PubMed)36921743
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Tranová, Thao $u Department of Pharmaceutical Technology, Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic
- 245 10
- $a Effect of co-processed excipient type on properties of orodispersible tablets containing captopril, tramadol, and domperidone / $c T. Tranová, J. Loskot, O. Navrátil, W. Brniak, J. Mužíková
- 520 9_
- $a An important feature of orodispersible tablets (ODTs) is the convenient administration of the drugs, in some cases, faster onset of action, stability maintenance, and dose precision. This work focused on the preparation of ODTs containing mannitol-based co-processed excipients Prosolv® ODT G2, Ludiflash® and Parteck® ODT in combination with tramadol, captopril, and domperidone by direct compression. Prosolv® ODT G2 showed high energy of plastic deformation due to the content of microcrystalline cellulose. Parteck® ODT provided compact tablets due to the content of granulated mannitol. All drugs decreased tensile strength, increased friability, prolonged disintegration time, and decreased the porosity of tablets. Tablets containing Prosolv® ODT G2 with captopril, domperidone, and tramadol; and Parteck® ODT with domperidone met the requirements for ODTs production, i.e., friability ≤ 1% and disintegration time ≤ 180 s, fast wetting time, high water absorption ratio, and adequate tensile strength. The disintegration time was tested using both the pharmacopeial method and the BJKSN-13 apparatus. The results indicate the significant difference between these methods, with the disintegration time being longer when tested with the BJKSN-13 instrument.
- 650 12
- $a pomocné látky $x chemie $7 D005079
- 650 _2
- $a příprava léků $x metody $7 D004339
- 650 _2
- $a domperidon $7 D004294
- 650 _2
- $a kaptopril $7 D002216
- 650 12
- $a tramadol $7 D014147
- 650 _2
- $a aplikace orální $7 D000284
- 650 _2
- $a rozpustnost $7 D012995
- 650 _2
- $a mannitol $x chemie $7 D008353
- 650 _2
- $a tablety $x chemie $7 D013607
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Loskot, Jan $u Department of Physics, Faculty of Science, University of Hradec Králové, Rokitanského 62, 500 03 Hradec Králové, Czech Republic. Electronic address: jan.loskot@uhk.cz
- 700 1_
- $a Navrátil, Ondřej $u Department of Chemical Engineering, University of Chemistry and Technology Prague, Technicka 3,166 28 Prague 6, Czech Republic
- 700 1_
- $a Brniak, Witold $u Department of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland
- 700 1_
- $a Mužíková, Jitka $u Department of Pharmaceutical Technology, Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic
- 773 0_
- $w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 636, č. - (2023), s. 122838
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36921743 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20230801132444 $b ABA008
- 999 __
- $a ok $b bmc $g 1963111 $s 1196754
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 636 $c - $d 122838 $e 20230313 $i 1873-3476 $m International journal of pharmaceutics $n Int. j. pharm. $x MED00002359
- LZP __
- $a Pubmed-20230718
